Felix Klingler

Felix Klingler is a Medical Specialist in Internal Medicine, Hematology, and Oncology at the II. Medical Clinic and Polyclinic, University Medical Center Hamburg-Eppendorf (UKE). He is affiliated with the Center for Oncology, focusing on clinical and translational research in hematologic malignancies and coagulation disorders. His work integrates oncology, hematology, and critical care medicine, emphasizing treatment protocols, complications management (e.g., hyperammonemia in leukemia patients), and immune mechanisms in acute myeloid leukemia (AML).

Research interests include AML pathophysiology, thrombosis in cancer, and immune checkpoint biomarkers. He contributes to clinical trials evaluating chemotherapy regimens and novel anticoagulant strategies. Collaborations involve the Department of Clinical Pharmacology and the ZMNH (Center for Molecular Neurobiology Hamburg).

Publications span 2018–2025, addressing topics like circulating tumor cells, myeloperoxidase regulation in coagulation, and therapeutic targeting of tissue factor pathways. His clinical role integrates patient care with research, advancing personalized oncology and critical care interventions.